Menopausal hormone therapies: their effect on mammographic density and breast cancer risk. - Test2 - elhamkhani - TriplyDB

Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.

Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.

http://www.wikidata.org/entity/Q30437825

about

Breast response to menopausal hormone therapy--aspects on proliferation, apoptosis and mammographic density.A "Spontaneously Shrinking" Breast Mass: Unusual Presentation of Invasive Tubular Carcinoma.The tissue selective estrogen complex: a promising new menopausal therapy

P2860

Q36761362-0314EA68-E488-4AB5-B88F-6D8E1B3A31F6 Q36964248-856BBE63-75AF-4AE5-89E3-C2AA4402BDE2 Q37277298-808595F0-9DF9-4C10-8F35-01E274A495BF

P2860

Menopausal hormone therapies: their effect on mammographic density and breast cancer risk.

http://www.wikidata.org/entity/Q30437825

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Menopausal hormone therapies: ...... ensity and breast cancer risk.

@ast

Menopausal hormone therapies: ...... ensity and breast cancer risk.

@en

type

label

Menopausal hormone therapies: ...... ensity and breast cancer risk.

@ast

Menopausal hormone therapies: ...... ensity and breast cancer risk.

@en

prefLabel

Menopausal hormone therapies: ...... ensity and breast cancer risk.

@ast

Menopausal hormone therapies: ...... ensity and breast cancer risk.

@en

P1433

Q30437825-0A8E3586-BAEE-44DE-86DC-C0EDBD6900F1

P1476

Q30437825-1380FEBC-C6A3-4781-95F5-79A9F2725619

P2093

Q30437825-EF0F1211-822C-46F9-9439-B2CA6D9315D8

P2860

Q30437825-119436F6-9528-496B-A95B-852823ECD3A9

Q30437825-3E0E5704-A136-4AEA-8223-960241E3BBC6

Q30437825-92AACDB6-50C2-4A09-A6DA-842C13040A1E

Q30437825-A193FAFD-71FF-4358-9E19-482B47A78573

Q30437825-A63E5F58-0022-45DD-BFE0-B49D0D0E4D2A

Q30437825-A8E3BAAF-60C9-4488-84E8-FD90B7599390

P304

Q30437825-AF24F3D9-AAA9-429B-83BA-C155496B60C9

P31

Q30437825-DE061FF4-E564-49C8-8DD5-C5F1EFD8E475

P356

Q30437825-CE879A54-70E1-4ECE-9846-3F2391A8E64E

P478

Q30437825-02A7925D-4B54-4DA4-9358-7173754CBF3B

P577

Q30437825-77B914A2-CD5D-40DA-9A74-4FE5AA9E65E6

P698

Q30437825-955EFD0D-8EEF-446D-94BD-DFB988F107CD

P356

09513590400030046

P1433

Gynecological Endocrinology

P1476

Menopausal hormone therapies: ...... ensity and breast cancer risk.

@en

P2093

Richard Santen

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

Quantitative assessment of mammographic breast density: relationship with breast cancer risk.

Risk of breast cancer with progestins: critical assessment of current data.

Mammographic densities and the prevalence and incidence of histological types of benign breast disease. Reference Pathologists of the Canadian National Breast Screening Study.

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.

P304

12-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09513590400030046

http://www.w3.org/2001/XMLSchema#string

P478

21 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16112950

http://www.w3.org/2001/XMLSchema#string